Dec 12, 2022
CAR-T-cell shows promise in patients with lymphoma of the brain and spinal cord in early trial
Posted by Nicholi Avery in categories: biotech/medical, neuroscience
๐๐๐-๐-๐๐๐ฅ๐ฅ ๐ฌ๐ก๐จ๐ฐ๐ฌ ๐ฉ๐ซ๐จ๐ฆ๐ข๐ฌ๐ ๐ข๐ง ๐ฉ๐๐ญ๐ข๐๐ง๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ฅ๐ฒ๐ฆ๐ฉ๐ก๐จ๐ฆ๐ ๐จ๐ ๐ญ๐ก๐ ๐๐ซ๐๐ข๐ง ๐๐ง๐ ๐ฌ๐ฉ๐ข๐ง๐๐ฅ ๐๐จ๐ซ๐ ๐ข๐ง ๐๐๐ซ๐ฅ๐ฒ ๐ญ๐ซ๐ข๐๐ฅ
๐ผ ๐พ๐ผ๐-๐-๐๐๐ก๐ก ๐ฉ๐๐๐ง๐๐ฅ๐ฎ ๐ ๐ฃ๐ค๐ฌ๐ฃ ๐๐จ ๐๐ญ๐๐๐๐๐ฉ๐๐๐๐ฃ๐ ๐๐๐ก๐ค๐ก๐๐ช๐๐๐ก (๐๐ญ๐-๐๐๐ก) ๐๐จ ๐จ๐๐๐ ๐๐ฃ๐ ๐จ๐๐ค๐ฌ๐จ ๐๐ฃ๐๐ค๐ช๐ง๐๐๐๐ฃ๐ ๐จ๐๐๐ฃ๐จ ๐ค๐ ๐๐๐๐๐๐๐๐ฎ ๐๐ฃ ๐ ๐จ๐ข๐๐ก๐ก ๐ฅ๐๐ก๐ค๐ฉ ๐ฉ๐ง๐๐๐ก ๐๐ฃ๐ซ๐ค๐ก๐ซ๐๐ฃ๐ ๐ฅ๐๐ฉ๐๐๐ฃ๐ฉ๐จ ๐ฌ๐๐ฉ๐ ๐ก๐ฎ๐ข๐ฅ๐๐ค๐ข๐ ๐ค๐ ๐ฉ๐๐ ๐๐ง๐๐๐ฃ ๐๐ฃ๐/๐ค๐ง ๐จ๐ฅ๐๐ฃ๐๐ก ๐๐ค๐ง๐, ๐ฟ๐๐ฃ๐-๐๐๐ง๐๐๐ง ๐พ๐๐ฃ๐๐๐ง ๐๐ฃ๐จ๐ฉ๐๐ฉ๐ช๐ฉ๐ ๐๐ฃ๐ซ๐๐จ๐ฉ๐๐๐๐ฉ๐ค๐ง๐จ ๐ง๐๐ฅ๐ค๐ง๐ฉ ๐๐ฉ ๐ฉ๐๐ 64๐ฉ๐ ๐ผ๐ข๐๐ง๐๐๐๐ฃ ๐๐ค๐๐๐๐ฉ๐ฎ ๐ค๐ ๐๐๐ข๐๐ฉ๐ค๐ก๐ค๐๐ฎ (๐ผ๐๐) ๐ผ๐ฃ๐ฃ๐ช๐๐ก ๐๐๐๐ฉ๐๐ฃ๐.
A CAR-T-cell therapy known as axicabtagene ciloleucel (axi-cel) is safe and shows encouraging signs of efficacy in a small pilot trial involving patients with lymphoma of the brain and/or spinal cord, Dana-Farber Cancer Institute investigators report at the 64th American Society of Hematology (ASH) Annual Meeting.